By OPEN MINDS Circle
Healthmap Solutions, Inc., a national population health management company focused on kidney disease, raised $100 million to support is ongoing expansion of its kidney health management services. Funds managed by Healthmap’s largest investor, WindRose Health Investors, led the financing along with participation from existing investors.
Healthmap is currently contracted to serve over 160,000 individuals living with kidney disease. It is contracted to manage over $3 billion in healthcare spend through risk-based arrangements with a number of the country’s leading health plans and at-risk providers.
The new funding will provide the company with the resources required for newly awarded business and the balance sheet strength to support the growing portion of Healthmap’s covered lives that are contracted under capitated arrangements. Healthmap’s growth is a result of its proven ability to improve care and lower costs for polychronic patients through the use of advanced technology, predictive analytics, machine learning, clinical expertise, and face-to-face interactions with providers and members. Additionally, the company’s approach has been effective across Medicare, Medicaid, and commercial populations living in disparate geographies.
Healthmap Solutions is an NCQA-accredited kidney population health management company serving health plans, health systems, accountable care organizations, and provider groups seeking a value-based solution to improve the lives of Americans living with chronic kidney disease. Using its advanced predictive analytics technology and clinical expertise, Healthmap provides early kidney disease identification and recommends clinically proven interventions to delay or slow disease progression. Healthmap Care Navigation teams work with patients and the full spectrum of a health plan’s providers to maintain access, minimize disruption and deliver personalized whole-person care from trusted providers. Healthmap’s approach is to proactively plan care transitions and optimize renal replacement therapy, with a focus on in-home dialysis treatment and transplant. This approach improves care, outcomes, and patient experience while lowering total medical costs for health plans and provider groups.
Contact information: Tom Gaffney, Chief Growth Officer, Healthmap Solutions, Inc., 4631 Woodland Corporate Boulevard, Suite 201, Tampa, FL 33614; 813-280-4846; Email: tom.gaffney@healthmapsolutions.com; Website: https://www.healthmapsolutions.com/